Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drugs for asthma.

Peter J Barnes1

  • 1National Heart and Lung Institute, Imperial College Faculty of Medicine, Dovehouse Street, London SW3 6LY, UK. p.j.barnes@imperial.ac.uk

Nature Reviews. Drug Discovery
|October 2, 2004
PubMed
Summary

Asthma treatment advances are ongoing, yet many patients remain uncontrolled. Research focuses on novel oral therapies and treatments for severe asthma, with curative prospects emerging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial dysfunction in lung ageing and disease.

European respiratory review : an official journal of the European Respiratory Society·2020
Same author

COPD 2020: new directions needed.

American journal of physiology. Lung cellular and molecular physiology·2020
Same author

Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.

The Lancet. Respiratory medicine·2020
Same author

Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Journal of immunology (Baltimore, Md. : 1950)·2020
Same author

Sex and gender: modifiers of health, disease, and medicine.

Lancet (London, England)·2020
Same author

Virus-Induced Asthma Exacerbations: SIRT1 Targeted Approach.

Journal of clinical medicine·2020

Area of Science:

  • Pulmonology
  • Pharmacology
  • Immunology

Background:

  • Asthma is a growing global health concern with inadequately controlled symptoms in many patients despite current treatments.
  • Combination inhalers (corticosteroid and long-acting beta(2) adrenoceptor agonist) represent the most effective current therapy.
  • Significant unmet needs exist for safe, effective oral treatments and therapies for severe asthma.

Purpose of the Study:

  • To review current and emerging therapies for asthma.
  • To identify novel therapeutic targets and strategies for improved asthma control.
  • To explore the potential for curative treatments in asthma.

Main Methods:

  • Review of current literature on asthma pharmacotherapy.
  • Analysis of ongoing clinical trials and preclinical research for new asthma treatments.
  • Evaluation of novel anti-inflammatory targets and mediator antagonists.

Main Results:

  • Current combination inhalers are effective but not universally sufficient.
  • Emerging therapies target mediators, cytokines, phosphodiesterase-4, p38 mitogen-activated protein kinase, and nuclear factor-kappaB.
  • While some targeted therapies may be too specific, broad anti-inflammatory approaches show promise.

Conclusions:

  • Despite advances, effective asthma control remains a challenge.
  • Development of novel oral and severe asthma treatments is a key research area.
  • The prospect of curative asthma treatments is on the horizon, driven by innovative anti-inflammatory strategies.

Related Experiment Videos